Edition:
India

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

1.40USD
17 Oct 2019
Change (% chg)

$-0.30 (-17.65%)
Prev Close
$1.70
Open
$1.60
Day's High
$1.60
Day's Low
$1.31
Volume
74,637
Avg. Vol
17,140
52-wk High
$10.98
52-wk Low
$1.31

Latest Key Developments (Source: Significant Developments)

Diffusion Pharmaceuticals Says Qtrly Loss Per Share $0.63
Friday, 9 Aug 2019 

Aug 8 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.DIFFUSION PHARMACEUTICALS INC - PHASE 2 ON-AMBULANCE TSC CLINICAL TRIAL FOR TREATMENT OF STROKE READY TO ENROLL.DIFFUSION PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.63.  Full Article

U.S. Awards Diffusion Rights For Use Of TSC Along With Stroke Therapeutic
Monday, 17 Dec 2018 

Dec 17 (Reuters) - Diffusion Pharmaceuticals Inc ::U.S. PATENT OFFICE AWARDS DIFFUSION EXCLUSIVE RIGHTS FOR USE OF TSC IN CONJUNCTION WITH ONLY FDA-APPROVED STROKE THERAPEUTIC.  Full Article

Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.DIFFUSION PHARMACEUTICALS INC - HAD CASH AND CASH EQUIVALENTS OF $11.0 MILLION AS OF SEPTEMBER 30.DIFFUSION PHARMACEUTICALS - BELIEVES CASH AND CASH EQUIVALENTS AT SEPT 30 ARE SUFFICIENT TO FUND OPERATIONS THROUGH SEPT 2019.DIFFUSION PHARMACEUTICALS - RECOGNIZED NON-CASH GOODWILL IMPAIRMENT CHARGE OF $4.2 MILLION IN QUARTER.DIFFUSION PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.13.  Full Article

Diffusion Pharmaceuticals ‍Had Cash And Cash Equivalents Of $8.9 Mln AS OF Dec 31, 2017​
Tuesday, 3 Apr 2018 

April 3 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.‍HAD CASH AND CASH EQUIVALENTS OF $8.9 MILLION AS OF DECEMBER 31, 2017​.  Full Article

Diffusion Pharmaceuticals Files Prospectus Related To Offering Of Common Stock
Tuesday, 6 Feb 2018 

Feb 6 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS INC FILES PROSPECTUS RELATED TO OFFERING UP TO 12.3 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING‍​.  Full Article

Diffusion Pharma Files For Stock Offering For Up To About $15 Mln
Thursday, 21 Dec 2017 

Dec 20 (Reuters) - Diffusion Pharmaceuticals Inc ::DIFFUSION PHARMACEUTICALS FILES FOR STOCK OFFERING FOR UP TO ABOUT $15 MILLION - SEC FILING.  Full Article

Diffusion Pharmaceuticals reports qtrly net income per diluted share $0.20‍​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Diffusion Pharmaceuticals Inc :Diffusion Pharmaceuticals Inc qtrly net income per diluted share $0.20‍​.Diffusion Pharmaceuticals Inc - ‍remain on track to begin enrolling patients by end of 2017 for tsc glioblastoma phase 3 pivotal study​.Diffusion Pharmaceuticals Inc - ‍awaiting confirmation from Nasdaq that co demonstrated compliance with all applicable requirements for continued listing​.  Full Article